Genetics 1 min read

FDA Approves Wireless Heart Device, Resilience Project Studies Healthy People, and a New Cancer Center Opens

By Rhonda Reinhart featured image The implantable CardioMEMS device recently approved by the FDA. Courtesy of St. Jude Medical

FDA approves new wireless device that monitors patients with heart failure: The implantable device, known as the CardioMEMS HF System, measures blood pressure and heart rate in patients who have been hospitalized with heart failure in the past year. The device allows doctors to monitor their patients’ condition remotely. Pick up the next issue of Genome, available later this summer, for an in-depth look at how digital medicine is changing healthcare.

Resilience Project looks for people with the genetic “superpower” to stay healthy: A massive new study will analyze DNA from volunteers in hopes of finding out why some people with genetic mutations known to cause severe childhood illnesses never get sick. The project’s ultimate goal: “We know that these ‘resilient’ people exist, and we believe if we can understand what is protecting them from illness, then we can make advances towards treating or even preventing these diseases.”

New cancer center aims to analyze 10,000 patient tumors in first year: Launched by Memorial Sloan Kettering Cancer Center, the Marie-Josée and Henry R. Kravis Center for Molecular Oncology will focus on improving cancer care through genomic analysis and precision oncology. The new center, which aims to analyze 10,000 tumors in its first year, was made possible by a $100 million gift from the Marie-Josée and Henry R. Kravis Foundation.